Showing 181-190 of 9754 results for "".
SDPA: Medical Director Dr. Hilary Baldwin Discusses Acne and Keloids Lectures
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-medical-director-dr-hilary-baldwin-discusses-acne-and-keloids-lectures/29508/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with conference medical director Hilary Baldwin, MD. She explains the key takeaways of her lectures on acne and keloids.Innovative Techniques for Forehead Wrinkles, Acne Laser Treatment, and More
https://practicaldermatology.com/conferences/maui-derm-2024/innovative-techniques-for-forehead-wrinkles-acne-laser-treatment-and-more/20250/Valerie D. Callender, MD, discusses the 3 cases she presented at Maui Derm 2024: filling in deeply etched forehead wrinkles with a resilient hyaluronic acid filler, treating acne with the 1726 nanometer laser, and treating melasma with a triple-combo procedure that includes maintenance therapy.Learn More About REVIAN® Red Hair Growth System
https://practicaldermatology.com/topics/hair-nails/learn-more-about-revian-red-hair-growth-system/19750/Discover a new option for hair loss patients! REVIAN Red is a patented dual-band LED wireless cap for at-home use ten minutes daily. Click Here to Become a REVIAN Red Professional. REVIAN Red is indicated to treat androgenetic alopecia and to promote hair growth in males who have Norwood-Hamilton clARION, Alexandrite Laser System by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/arion-alexandrite-laser-system-by-quantel-derma/19377/ARION by Quantel Derma - High-end Solution for Hair Removal. ARION is the alexandrite laser system for effective hair removal with 755 nm wavelength. The versatile system is also suitable for treatment of vascular lesions and benign pigmented skin changes. The special Burst Mode with short sub-pulseAnti-OX40 Ligand Antibody Trials
https://practicaldermatology.com/series/updates-atopic-dermatitis/anti-ox40-ligand-antibody-trials/29531/Lead study author Stephan Weidinger, MD, PhD, Director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein, discusses the phase 2b STREAM-AD trial, evaluating amlitelimab in adult patients with moderate-to-severe atopic dermatitis.DermWireTV: PCA to Space Station; ASDS Pandemic Data; LaRoche-Posay, GW Partnership
https://practicaldermatology.com/topics/practice-management/dermwiretv-pca-to-space-station-asds-pandemic-data-laroche-posay-gw-partnership/20059/The "Great Resignation" forcing some dermatology practices to operate with reduced staffing is just one of the lingering impacts of the COVID-19 pandemic on practices, according to results of a survey by the American Society for Dermatologic Surgery. PCA skin is sending the first-ever private sectorCash Savings Alternative: Increase Returns & Maintain Liquidity
https://practicaldermatology.com/topics/practice-management/cash-savings-alternative-increase-returns-maintain-liquidity--wnhimepo/18366/OJM Group Director of Financial Advisors Michael Lewellen, CFP provides an overview and financial example of a cash savings alternative that offers 100% liquidity while providing a higher return than traditional investment vehicles. Click here to request or download a free copy of Wealth ProtectionSkin Resurfacing, Pixel RF from Alma Lasers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/-skin-resurfacing-pixel-rf-from-alma-lasers/19241/Skin resurfacing with the innovative Pixel RF from Alma Lasers. Ready to fight the hands of time? Click here for more info: http://www.AlmaLasers.comVShape Facial Contouring by Alma Lasers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/vshape-facial-contouring-by-alma-lasers/19251/VShape is a non-invasive and pain-free treatment for facial contouring. Performed throughout the world using Alma Lasers Accent Ultra medical aesthetic technology. vShape: Bipolar RF TechnologyFDA Approves New Drug for Prurigo Nodularis; Long-Term Use of Dupilumab Examined
https://practicaldermatology.com/series/dermwire-tv/fda-approves-new-drug-prurigo-nodularis-long-term-use-dupilumab-examined/26925/In this week's DermwireTV, the FDA approves Galderma's Nemluvio for adults with prurigo nodularis; a study examines the long-term use of dupilumab for atopic dermatitis; and Andrew Mastro discusses how to talk to patients about starting a Janus kinase (JAK) inhibitor for AD.